ENZON PHARMACEUTIC COM USD0.01 (ENZN)

0.37
0.00 0.27
OTC
Prev Close 0.37
Open 0.37
Day Low/High 0.37 / 0.38
52 Wk Low/High 0.37 / 1.10
Volume 65.30K
Exchange OTC
Shares Outstanding 43.87B
Market Cap 16.27M
Div & Yield N.A. (N.A)

Latest News

Enzon Pharmaceuticals (ENZN) Is Today's Strong On High Volume Stock

Enzon Pharmaceuticals (ENZN) Is Today's Strong On High Volume Stock

Trade-Ideas LLC identified Enzon Pharmaceuticals (ENZN) as a strong on high relative volume candidate

Strong On High Volume: Enzon Pharmaceuticals (ENZN)

Strong On High Volume: Enzon Pharmaceuticals (ENZN)

Trade-Ideas LLC identified Enzon Pharmaceuticals (ENZN) as a strong on high relative volume candidate

Enzon Pharmaceuticals (ENZN) Weak On High Volume Today

Enzon Pharmaceuticals (ENZN) Weak On High Volume Today

Trade-Ideas LLC identified Enzon Pharmaceuticals (ENZN) as a weak on high relative volume candidate

Enzon Pharmaceuticals (ENZN) Is Today's Strong On High Volume Stock

Enzon Pharmaceuticals (ENZN) Is Today's Strong On High Volume Stock

Trade-Ideas LLC identified Enzon Pharmaceuticals (ENZN) as a strong on high relative volume candidate

DELiA*s Rebounds As Reports Suggest Delisting May Be Imminent

DELiA*s Rebounds As Reports Suggest Delisting May Be Imminent

Billionaire stock picks dELiA*s, Inc. (NASDAQ:DLIA), AngloGold Ashanti Limited (ADR) (NYSE:AU) and Enzon Pharmaceuticals Inc (NASDAQ:ENZN) made big gains early in the day this Monday. Moving in the o...

Bankruptcy Filing Fallout Continues for NII Holdings

Bankruptcy Filing Fallout Continues for NII Holdings

Corinthian Colleges Inc (NASDAQ:COCO), Rock Creek Pharmaceuticals Inc (NASDAQ:RCPI) and dELiA*s, Inc. (NASDAQ:DLIA) are today's top-gaining stocks. The losers are NII Holdings Inc (NASDAQ:NIHD), T...

George Soros Picks KIOR, RSH, BIOL Soar on Monday

George Soros Picks KIOR, RSH, BIOL Soar on Monday

KiOR Inc (NASDAQ:KIOR), RadioShack Corporation (NYSE:RSH) and BIOLASE Inc (NASDAQ:BIOL) are today's top-gaining billionaire stock picks. On the losing end are NII Holdings Inc (NASDAQ:NIHD), dELiA...

Enzon Pharmaceuticals Inc Stock Upgraded (ENZN)

Enzon Pharmaceuticals Inc Stock Upgraded (ENZN)

Enzon Pharmaceuticals (Nasdaq:ENZN) has been upgraded by TheStreet Ratings from a sell to hold.

Enzon Adopts Stockholder Rights Plan In An Effort To Protect Net Operating Loss Carryforwards

Enzon Adopts Stockholder Rights Plan In An Effort To Protect Net Operating Loss Carryforwards

Enzon Pharmaceuticals, Inc. (“Enzon” or the “Company”) (Nasdaq:ENZN) announced today that its Board of Directors (the “Board”) has adopted a stockholder rights plan (the “Rights...

Enzon Pharmaceuticals Stock Sees Short Interest Make 47.2% Move

Enzon Pharmaceuticals Stock Sees Short Interest Make 47.2% Move

The most recent short interest data has been released by the NASDAQ for the 02/14/2014 settlement date, which shows a 372,586 share increase in total short interest for Enzon Pharmaceuticals Inc , to 1,161,223, an increase of 47.24% since 01/31/2014. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Short Interest In Enzon Pharmaceuticals Drops 39%

Short Interest In Enzon Pharmaceuticals Drops 39%

The most recent short interest data has been released by the NASDAQ for the 12/31/2013 settlement date, which shows a 542,374 share decrease in total short interest for Enzon Pharmaceuticals Inc , to 852,999, a decrease of 38.87% since 12/13/2013. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

5 Health Care Stocks Under $10 to Watch

5 Health Care Stocks Under $10 to Watch

Regardless of the reason behind it, when a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

ENZN July Options Begin Trading

ENZN July Options Begin Trading

Investors in Enzon Pharmaceuticals Inc saw new options become available today, for the July expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ENZN options chain for the new July contracts and identified the following put contract of particular interest.

Stocks Heat Up as Budget Talks Progress

Stocks Heat Up as Budget Talks Progress

Bank of America, Home Depot and General Electric are among the biggest gainers on the Dow.

Stock Futures Rise Despite Weak Manufacturing Data

Stock Futures Rise Despite Weak Manufacturing Data

Stock futures rise Monday amid signs of progress in the U.S. 'fiscal cliff' talks.

Enzon Stock Hits New 52-Week Low (ENZN)

Enzon Pharmaceuticals (Nasdaq:ENZN) hit a new 52-week low Friday as it is currently trading at $7.19, below its previous 52-week low of $7.20 with 102,690 shares traded as of 3:25 p.m. ET. Average volume has been 366,100 shares over the past 30 days.

Enzon Announces Reduction In Force To Align Operations With Research And Development Activities

Enzon Pharmaceuticals, Inc. (Nasdaq: ENZN) today announced that it is implementing a plan to reduce its workforce and operating costs to more closely align its resources with the Company’s research and development ...

Enzon Stock Hits New 52-Week Low (ENZN)

Enzon Pharmaceuticals (Nasdaq:ENZN) hit a new 52-week low Thursday as it is currently trading at $7.38, below its previous 52-week low of $7.42 with 129,976 shares traded as of two p.m. ET. Average volume has been 377,600 shares over the past 30 days.

Enzon Pharmaceuticals Inc. Stock Downgraded (ENZN)

Enzon Pharmaceuticals (Nasdaq:ENZN) has been downgraded by TheStreet Ratings from from a hold to sell.

Enzon Stock Hits New 52-Week Low (ENZN)

Enzon Pharmaceuticals (Nasdaq:ENZN) hit a new 52-week low Thursday as it is currently trading at $8.86, below its previous 52-week low of $9.09 with 130,992 shares traded as of 11 a.m. ET. Average volume has been 392,200 shares over the past 30 days.

Enzon Stock Hits New 52-Week Low (ENZN)

Enzon Pharmaceuticals (Nasdaq:ENZN) hit a new 52-week low Wednesday as it is currently trading at $9.92, below its previous 52-week low of $9.93 with 59,540 shares traded as of 10:26 a.m. ET. Average volume has been 403,700 shares over the past 30 days.

Enzon Stock Hits New 52-Week Low (ENZN)

Enzon Pharmaceuticals (Nasdaq:ENZN) hit a new 52-week low Friday as it is currently trading at $9.97, below its previous 52-week low of $10 with 901,487 shares traded as of four p.m. ET. Average volume has been 434,900 shares over the past 30 days.

ENZON Names Ana I. Stancic Chief Financial Officer

Enzon Pharmaceuticals, Inc. (Nasdaq: ENZN) today announced that Ana I.

Enzon Announces Discontinuation Of PEG-SN38 Program In Metastatic Colorectal Carcinoma In Light Of Evolving Standards Of Care

Enzon Pharmaceuticals, Inc. (Nasdaq: ENZN) today announced that, in light of evolving standards of care for the treatment of metastatic colorectal cancer (mCRC), the Company will discontinue its PEG-SN38 (EZN-2208)...

2 New Stock Picks From Baupost's Klarman

Klarman picked up a gold and networking stock in the first quarter.

Enzon Reports 1st Quarter 2011 Results

Enzon Pharmaceuticals, Inc. (Nasdaq: ENZN) today announced its financial results for the first quarter of 2011.

Enzon Presents Data At 2011 AACR Meeting

Enzon Pharmaceuticals, Inc. (Nasdaq: ENZN) today presented updated data from clinical and preclinical studies of four investigational messenger RNA (mRNA) antagonists based on the company’s locked nucleic acid (LNA) ...

Enzon Appoints Richard Mulligan, Ph.D. Vice-Chairman Of The Board; Adopts Majority Vote Standard For Election Of Directors

Enzon Pharmaceuticals, Inc. (Nasdaq: ENZN) today announced that Richard C.